| Finding | Percentage | Cases |
|---|---|---|
| Gender | ||
| Male | 44.4% | 4/9 |
| Female | 55.6% | 5/9 |
| Indifferent | 0% | 0/9 |
| Unknown | 0% | 0/9 |
| General | ||
| 22.2% | 2/9 | |
| 77.8% | 7/9 | |
| 11.1% | 1/9 | |
| 66.7% | 6/9 | |
| 22.2% | 2/9 | |
| 33.3% | 3/9 | |
| 100% | 9/9 | |
| 100% | 9/9 | |
| 55.6% | 5/9 | |
| 100% | 5/5 | |
| Neurology | ||
| 55.6% | 5/9 | |
| 44.4% | 4/9 | |
| 22.2% | 2/9 | |
| Facial abnormalities | ||
| 66.7% | 6/9 | |
| 77.8% | 7/9 | |
| 55.6% | 5/9 | |
| 66.7% | 6/9 | |
| Visual and hearing impairments | ||
| 44.4% | 4/9 | |
| 44.4% | 4/9 | |
| Heart | ||
| 33.3% | 3/9 | |
| Pulmonary | ||
| Abnormality of the lungs | 0% | 0/9 |
| Gastrointestinal | ||
| 11.1% | 1/9 | |
| Urogenital | ||
| 44.4% | 4/9 | |
| Skeleton | ||
| 77.8% | 7/9 | |
| Skin / Hair / Nails | ||
| 100% | 9/9 | |
| Endocrine / Immunological / Metabolic | ||
| 33.3% | 3/9 | |
| Metabolic | 0% | 0/9 |
| 44.4% | 4/9 | |
| Neoplasia | ||
| Neoplasia | 0% | 0/9 |
| Inheritance | ||
| 100% | 9/9 | |
PHF5A